Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
AssigneeMerck Frosst Canada, Inc.
InventorsChun Sing Li, Yeeman K. Ramtohul, Jean-Philippe Leclerc
Life of this patent
Estimating the term…
Abstract
Heteroaromatic compounds of structural formula I are inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD). The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease; atherosclerosis; obesity; diabetes; neurological disease; Metabolic Syndrome; insulin resistance; cancer; liver steatosis; and non-alcoholic steatohepatitis. HetAr−W−X−Ar (I)
Claims17
A compound of structural formula I:
- HetAr—W—X—Ar (I)
- or a pharmaceutically acceptable salt thereof;
- wherein
- X is —O—, —S—, —S(O)—, —S(O)2—, —NR9—, or —CR10R11—;
- W is selected from the group consisting of:
- HetAr is heteroaryl selected from the group consisting of:
- R1 is heteroaryl selected from the group consisting of:
- wherein
- Rb is —(CH2)rCO2H, —(CH2)rCO2C1-3 alkyl, —(CH2)r—Z—(CH2)pCO2H, or —(CH2)r—Z—(CH2)pCO2C1-3 alkyl;
- Rc is —(CH2)mCO2H, —(CH2)mCO2C1-3 alkyl, —(CH2)m—Z—(CH2)pCO2H, or —(CH2)m—Z—(CH2)pCO2C1-3 alkyl;
- and wherein said R1 heteroaryl ring is optionally substituted with a substituent selected from the group consisting of cyano, halogen, C1-4 alkyl, C1-4 alkoxy, C1-4 alkylthio, C1-4 alkylsulfonyl, and trifluoromethyl;
- each R2 is independently selected from the group consisting of:
- hydrogen,
- halogen,
- hydroxy,
- cyano,
- amino,
- nitro,
- C1-4 alkyl, optionally substituted with one to five fluorines,
- C1-4 alkoxy, optionally substituted with one to five fluorines,
- C1-4 alkylthio, optionally substituted with one to five fluorines,
- C1-4 alkylsulfonyl,
- carboxy,
- alkyloxycarbonyl, and
- C1-4 alkylcarbonyl;
- Ar is phenyl or naphthyl optionally substituted with one to five R3 substituents;
- each R3 is independently selected from the group consisting of:
- C1-6 alkyl,
- C1-6 alkenyl,
- (CH2)n-phenyl,
- (CH2)n-naphthyl,
- (CH2)n-heteroaryl,
- (CH2)n-heterocyclyl,
- (CH2)nC3-7 cycloalkyl,
- halogen,
- nitro,
- (CH2)nOR4,
- (CH2)nN(R4)2,
- (CH2)nC≡N,
- (CH2)nCO2R4,
- (CH2)nNR4SO2R4
- (CH2)nSO2N(R4)2,
- (CH2)nS(O)0-2R4,
- (CH2)nNR4C(O)N(R4)2,
- (CH2)nC(O)N(R4)2,
- (CH2)nNR4C(O)R4,
- (CH2)nNR4CO2R4,
- (CH2)nC(O)R4,
- (CH2)nC(O)N(R4)2,
- (CH2)s—Z—(CH2)t-phenyl,
- (CH2)s—Z—(CH2)t-naphthyl,
- (CH2)s—Z—(CH2)t-heteroaryl,
- (CH2)s—Z—(CH2)t-heterocyclyl,
- (CH2)s—Z—(CH2)t—C3-7 cycloalkyl,
- (CH2)s—Z—(CH2)t—OR4,
- (CH2)s—Z—(CH2)t—N(R4)2,
- (CH2)s—Z—(CH2)t—NR4SO2R4,
- (CH2)s—Z—(CH2)t—C≡N,
- (CH2)s—Z—(CH2)t—CO2R4,
- (CH2)s—Z—(CH2)t—SO2N(R4)2,
- (CH2)s—Z—(CH2)t—S(O)0-2R4,
- (CH2)s—Z—(CH2)t—NR4C(O)N(R4)2,
- (CH2)s—Z—(CH2)t—C(O)N(R4)2,
- (CH2)s—Z—(CH2)t—NR4C(O)R4,
- (CH2)s—Z—(CH2)t—NR4CO2R4,
- (CH2)s—Z—(CH2)t—C(O)R4,
- CF3,
- CH2CF3,
- OCF3, and
- OCH2CF3;
- in which phenyl, naphthyl, heteroaryl, cycloalkyl, and heterocyclyl are optionally substituted with one to three substituents independently selected from halogen, hydroxy, C1-4 alkyl, trifluoromethyl, and C1-4 alkoxy;
- and wherein any methylene (CH2) carbon atom in R3 is optionally substituted with one to two groups independently selected from fluorine, hydroxy, and C1-4 alkyl;
- or two substituents when on the same methylene (CH2) group are taken together with the carbon atom to which they are attached to form a cyclopropyl group;
- Z is O, S, or NR4;
- each R4 is independently selected from the group consisting of
- hydrogen,
- C1-6 alkyl,
- (CH2)n-phenyl,
- (CH2)n-heteroaryl,
- (CH2)n-naphthyl, and
- (CH2)nC3-7 cycloalkyl;
- wherein alkyl, phenyl, heteroaryl, and cycloalkyl are optionally substituted with one to three groups independently selected from halogen, C1-4 alkyl, and C1-4 alkoxy;
- or two R4 groups together with the atom to which they are attached form a 4- to 8-membered mono- or bicyclic ring system optionally containing an additional heteroatom selected from O, S, NH, and NC1-4 alkyl;
- each R6 and R7 are independently hydrogen or C1-3 alkyl, wherein alkyl is optionally substituted with one to five fluorines;
- each R8 is independently selected from the group consisting of hydrogen, halogen, and C1-4 alkyl wherein alkyl is optionally substituted with one to five fluorines;
- R9, R10, and R11 are each independently hydrogen or C1-3 alkyl, wherein alkyl is optionally substituted with one to five fluorines;
- u is an integer from 0 to 2;
- r is an integer from 0 to 3;
- m is an integer from 1 to 3;
- each p is independently an integer from 1 to 3;
- each n is independently an integer from 0 to 2;
- each s is independently an integer from 1 to 3;
- and
- each t is independently an integer from 1 to 3.
15-19. (canceled)
The method of claim 21 wherein said lipid disorder is selected from the group consisting of dyslipidemia, hyperlipidemia, hypertriglyceridemia, atherosclerosis, hypercholesterolemia, low HDL, and high LDL.
Dependencies are inferred from the claim text.